ArticleAnnals of surgical oncology2025
Redefining Resection Margin Status and Its Implications for Adjuvant Radiotherapy in Hilar Cholangiocarcinoma: A 10-Year Retrospective Study of Recurrence Patterns.
Article in Annals of surgical oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThis study aimed to redefine resection margin classification by considering the clearance length and high-grade dysplasia of the margin, as well as to evaluate the association between adjuvant radiotherapy and recurrence patterns.
methodsThe study retrospectively analyzed 218 patients who underwent curative-intent resection between 2012 and 2022. Resection margins were categorized as wide-clear (>2 mm), narrow-clear (≤2 mm or clear margin after re-resection), dysplastic, or invasive. Recurrence patterns and the effect of adjuvant radiotherapy on local recurrence-free survival were assessed across these margin groups.
resultsOverall recurrence occurred for 62.1% of the patients. The local recurrence rates per margin were as follows: wide-clear (23.6%), narrow-clear (32.6%), dysplastic (35.3%), and invasive (31.4%). The patients receiving adjuvant radiotherapy had a significantly lower local recurrence (adjusted hazard ratio [HR], 0.097; 95% confidence interval CI 0.033-0.286; p < 0.001). Notably, no local recurrence was observed in patients from the wide-clear, narrow-clear, or dysplastic groups who received adjuvant radiotherapy. In the invasive-margin group, the patients who received adjuvant radiotherapy had a lower risk of local recurrence (adjusted HR 0.04; 95% CI 0.01-0.24; p < 0.01).
conclusionsThe refined margin classification showed distinct recurrence patterns. Adjuvant radiotherapy was associated with local recurrence in patients with invasive margins and in those with dysplastic or narrow-clear margins, including cases with R0 status achieved through re-resection. More tailored postoperative strategies that incorporate the margin status might help to address recurrence risk of hilar cholangiocarcinoma.
Indexed as
Identifiers
40975740What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.